Cristina Molina Rosell

Title: Cristina Molina Rosell: Innovator in Antibiotic Synthesis

Introduction

Cristina Molina Rosell is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the synthesis of semi-synthetic antibiotics. Her innovative work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Cristina holds a patent for a method that focuses on the synthesis of semi-synthetic monobactamic or β-Lactamic antibiotics. This method utilizes derivatives stabilized by various methods of penicillin G acylase from different microbial sources. The process is designed according to a thermodynamically controlled strategy in monophase water/cosolvent organic apolar systems. The concentration of the cosolvent varies between 30% and 90%, with temperature settings ranging from -10°C to 50°C and pH levels between 4.5 and 8.5. The concentrations of the antibiotic nucleus range from 0.5 to 875 mM, while the acyl donor varies between 0.2 mM and 1M. This innovative approach is applicable to the pharmaceutical industry.

Career Highlights

Cristina is associated with the Consejo Superior de Investigaciones Científicas, where she continues her research and development in antibiotic synthesis. Her work has garnered attention for its potential applications in improving antibiotic production and efficacy.

Collaborations

Cristina has collaborated with notable colleagues, including Jose Manuel Guisan Seijas and Roberto Fernandez Lafuente. These partnerships have further enriched her research and contributed to advancements in the field.

Conclusion

Cristina Molina Rosell is a trailblazer in the synthesis of semi-synthetic antibiotics, with a patent that showcases her innovative approach. Her contributions to the pharmaceutical industry are noteworthy and reflect her dedication to advancing medical science.